• Senior Vice President for Research, Augusta University
• Associate Dean for Research, Medical College of Georgia
• Professor, Department of Obstetrics & Gynecology
• Leon Henri Charbonnier Endowed Chair in Reproductive Endocrinology
Michael P. Diamond, MD, is an internationally renowned clinical and translational investigator, who is recognized for many scientific contributions, including within the field of Reproductive Endocrinology and Infertility and has previously served as an IRB member or Chair for over 16 years.
Dr. Diamond has been funded by six NIH Institutes and served as Principal Investigator or Co-PI on over 45 commercial clinical trials on diverse topics including infertility, insulin sensitivity, postoperative adhesions, uterine fibroids, ovulation induction, menstrual migraines, osteoporosis, endometriosis, and sexual dysfunction. He has served on multiple NIH study sections and special review committees, as well as served as a member and subsequently a consultant to the Obstetrics and Gynecology Device Panel of the Center for Devices and Radiological Health of the Food and Drug Administration.
Dr. Diamond is a past President of his subspecialty society, the Society of Reproductive Endocrinology and Infertility, and has served as the President of the Society of Reproductive Surgeons, as well as Chair of the American Society for Reproductive Medicine’s Androgen Excess, and the Environment and Reproduction Special Interest Groups.
Read more about Dr. Diamond
Dr. Diamond completed undergraduate studies at Vassar College in Poughkeepsie, New York, medical school at Vanderbilt University in Nashville, Tennessee, followed by internship and residency in Obstetrics and Gynecology at the same institution; and his fellowship in Reproductive Endocrinology and Infertility at Yale University in New Haven, Connecticut. He has specific expertise, interest, and experience in many areas of investigation including the development of postoperative adhesions, surgical treatment of uterine fibroids and endometriosis, oxidative stress, carbohydrate metabolism, androgen physiology, and the induction of ovulation. Dr. Diamond has extensive experience in research study design, organization, and implementation. He has a long track record of conduct of prospective clinical studies, as well as randomized controlled clinical trials. He has played leading roles in design and conduct of the preclinical/clinical studies leading to FDA approval of the first two agents for reduction of postoperative intraabdominal adhesions approved and available in the United States (Interceed and Seprafilm).
Dr. Diamond is an internationally renowned clinical and translational investigator, who is recognized for many scientific contributions, including within the field of Reproductive Endocrinology and Infertility. His contributions include publications of over 575 peer reviewed manuscripts, 135 chapters, and 880 abstracts. Additionally he has edited or co-edited over 20 books and journal issues, and has given over 820 scientific presentations. Dr. Diamond has also been extensively involved in health care provider education, including participating in the training of medical students and OB/GYN residents. He has also served as Reproductive Endocrinology and Infertility Fellowship Director, in total training over thirty REI fellows.
Dr. Diamond has been funded by six NIH Institutes, including NICHD to conduct randomized clinical trials utilizing the euglycemic, hyperinsulinemic clamp and hyperglycemic clamp techniques to evaluate the role of androgens on insulin sensitivity in men and women. He serves as AU’s PI on the NICHD Cooperative Reproductive Medicine Network grant which has conducted clinical trials on diagnosis of luteal phase defects, ovulation induction for women with polycystic ovarian syndrome, and ovarian stimulation for unexplained infertility. He also serves as Recruitment Director for the NICHD Women’s Reproductive Health Research Career Development grant, which trains obstetrician/gynecologists to become independent investigators. He has also participated in the NICHD National Cooperative Program for Infertility Research examining hormonal perturbations in women with otherwise “unexplained” infertility, as well as collaborated in trials examining the effect of organochlorines on male factor infertility funded by NIEHS, studies examining the effect of testosterone replacement on cognitive function in hypogonadal men funded by NIA, and the effect of sex steroids and gender on apnic thresholds funded by the VA. Dr. Diamond has also served as Principal Investigator or Co-PI on over 45 commercial clinical trials on diverse topics including postoperative adhesions, uterine fibroids, ovulation induction, menstrual migraines, osteoporosis, endometriosis, and sexual dysfunction. He has served on multiple study sections and special review committees for the NIH, as well as a member and subsequently a consultant to the Obstetrics and Gynecology Device Panel of the Center for Devices and Radiological Health of the Food and Drug Administration. He is a past President of his subspecialty Society, the Society for Reproductive Endocrinology and Infertility, and the Society of Reproductive Surgeons. He has served on the Board of Directors for many other national and international societies including the American Society for Reproductive Medicine, the Society for Gynecologic Surgeons, and the AAGL Advancing Minimally Invasive Gynecology Worldwide.
Christine Nelson, BSN, MBA
Laura Meyer Chapman
Alyssa Fail, MS
|Center for Undergraduate Research and Scholarship
|Clinical Research Pharmacy
|Clinical Trial Contract Negotiator
|Clinical Trials Office (CTO)
|Division of Environmental Health & Safety (EHS)
|Division of Lab Animal Services
|Division of Sponsored Program Administration (DSPA)
|Institutional Review Board (IRB)
|Library Services for Research
|Office of Innovation Commercialization (OIC)
|Office of Senior Vice President for Research
|Research Development Services (RDS)
|Summerville Interdisciplinary Research Office